014 - Why now is the most important time for selecting a CMO - a podcast by Ed Narke, Meranda Parascandola
from 2020-10-30T10:00
What We Covered
- 01:19 – Ed, Brian and Meranda welcome to the show Dr. Rick Offerman who speaks to his experience as a process chemist, the drug development process and what goes into selecting a solvent
- 15:41 – The importance of selecting the right CMO partner
- 19:05 – Questions that must be asked in the beginning of the drug manufacturing process
- 23:14 – Dr. Rick breaks down best practices in cost-control
- 30:16 – The importance of the project timeline
- 40:13 – Dr. Rick takes a moment to recognize those who greatly influenced his career
- 46:23 – Ed, Brian and Meranda thank Dr. Rick for joining the show
Tweetable Quotes
“A lot of CMOs are now going to a ‘one-stop shop’ type model. So basically they’ll say, ‘Yeah we’ll take you all the way from gram quantities right through commercial. We can do your API and your drug substance.’ But there’s still a lot of smaller shops out there that can do small scale pre-clinical work.”
“Cost is always a factor [in selecting a solvent] but it’s not the major one.”
“You’re gotta have an integrated approach all the way through the system to understand the API that you’re producing, the impurity profile, the crystal morphology, the polymorphs, that sort of thing.”
“Realistically, when you look at the cost of an API as a percentage of a drug product, it’s usually fairly low.”
“If the analytical people aren’t up and ready to go, then when the chemists start running stuff in the hoods, how do they analyze it? We don’t have methods, so we’re kinda going on a wing and a prayer.”
Relevant Links
Design Space InPharmatics - LinkedIn
Design Space InPharmatics - Twitter
Further episodes of CMC Live - Chemistry, Manufacturing
Further podcasts by Ed Narke, Meranda Parascandola
Website of Ed Narke, Meranda Parascandola